Capivasertib (Truqap,Capivadx)

Capivasertib is the first approved highly selective ATP-competitive AKT kinase inhibitor, and is commonly used in combination with fulvestrant.

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Capivasertib Medication Guide

Capivasertib Indications

Capivasertib, in combination with fulvestrant, is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal g···【More】
Update: 02 Apr,2026Source: BigbearViews: 88
Side Effects of Capivasertib

Capivasertib, a breast cancer treatment targeting a specific gene abnormality, has demonstrated significant clinical efficacy. Like many other medicat···【More】
Update: 02 Apr,2026Source: BigbearViews: 86
Capapasetinib Dosage Guidelines

To help patients better understand and correctly use capapasetinib, the following detailed dosage guidelines are provided to ensure effective treatmen···【More】
Update: 02 Apr,2026Source: BigbearViews: 89